Fusion Antibodies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Fusion Antibodies generated cash of -$1,769,000, which is less than the previous year. Cash used in financing activities reached the amount of $2,770,000 last year. Net change in cash is therefore $1,004,000.
Cash Flow
| 2016 | 346.57K | -35.76K | -496 |
|---|---|---|---|
| 2018 | 77.19K | -444.59K | 4.57M |
| 2020 | -166K | -109K | -172K |
| 2021 | -1.15M | -365K | 2.66M |
| 2023 | -1.75M | -114K | 7K |
| 2024 | -1.76M | 1K | 2.77M |
FAB.L Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 195K | 2.04M | 1.53M | 1.98M | 285.68K | 103.63K |
Operating activities | ||||||
Net income | -2.22M | -2.59M | -2.89M | -697K | -699.94K | 1.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 220K | 372K | 714K | 622K | 69.62K | 22.23K |
Stock-based compensation expense | 86K | 35K | 19K | 83K | 330.17K | 133.62K |
| Deferred income tax benefit | 86K | 35K | 19K | 83K | 330.17K | 133.62K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 133K | 819K | -553K | 169K | -225.32K | -66.70K |
Inventories | 79K | 46K | -140K | -97K | -11.55K | 0 |
Accounts payable | 0 | -299K | 5K | 99K | 14.97K | 209.76K |
Cash generated by operating activities | -1.76M | -1.75M | -1.15M | -166K | 77.19K | 346.57K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2K | -114K | -365K | -109K | -444.59K | -35.76K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 1K | -114K | -365K | -109K | -444.59K | -35.76K |
Financing activities | ||||||
Common Stock Issued | 2.80M | 0 | 2.81M | 0 | 4.59M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -33K | 7K | -150K | -172K | -25.18K | 0 |
Cash used in financing activities | 2.77M | 7K | 2.66M | -172K | 4.57M | -496 |
Net Change In Cash | 1.00M | -1.85M | 1.14M | -447.33K | 4.20M | 310.31K |
Cash at end of period | 1.19M | 195K | 2.68M | 1.53M | 4.49M | 413.94K |
| Data source | Data source | Data source | Data source | Data source | Data source |